Home >
Medicine Info >
Lafumac 10 mg Tablet
Loading interface...

Lafumac 10 mg Tablet

Manufactured byMACLEODS PHARMACEUTICALS PVT.LTD
ContainsLafutidine
Description
Lafumac 10 mg Tablet is an effective medicine that is used to reduce the amount of acid produced in the stomach. It is used to treat stomach acid-related disorders such as gastroduodenal ulcers, gastric mucosal lesions, etc. This medicine is not recommended for use in patients below 18 years of age.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Lafumac 10 mg Tablet

  • Constipation
  • Rash
  • Nausea or Vomiting
  • Dizziness
  • Sore throat
  • Headache
  • Insomnia
  • Confusion

Uses of Lafumac 10 mg Tablet

What is it prescribed for?

  • Gastric ulcer
  • Duodenal ulcer
  • Gastric mucosal lesions
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to lafutidine or any other inactive ingredients present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
General warnings

Use in children

This medicine is not recommended for use in children since the safety and efficacy of use are not clinically established.

Use in elderly

This medicine should be used with caution in the elderly patients due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative should be considered under your doctor's supervision.

Renal impaiment

This medicine should be used with caution in patients with kidney diseases or patients on dialysis due to the increased risk of worsening of the patient's condition. Close monitoring of renal function is necessary for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Liver impairment

This medicine should be used with caution in patients with liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is necessary for such patients during treatment with this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Anaphylactic reactions

This medicine may cause shock and anaphylactic reactions in some patients. Report any symptoms such as a pale skin, dizziness, breathing difficulty, etc. to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine
Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller amounts than prescribed. Report any unusual symptoms to the doctor immediately. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken after food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by reducing the amount of acid produced in the stomach.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

H2 antagonists

Schedule

Schedule H

[Internet]. Ucb.com. 2018 [cited 15 January 2018]. Available from:

https://www.ucb.com/_up/ucb_com_products/documents/STOGAR-April2005(050414)_tcm62-3741_tcm81-8593.pdf
Akiba Y. Lafutidine, a Protective H2 Receptor Antagonist, Enhances Mucosal Defense in Rat Esophagus. 2018.

[Internet]. Zuventus.co.in. 2018 [cited 15 January 2018]. Available from:

http://www.zuventus.co.in/doctor_wise_products_selected.aspx?Medi_Id=40

Kumar S. A Comparative Evaluation of Lafutidine andRabeprazole in the Treatment of Gastritis andPeptic Ulcer: A Double-blind, RandomizedStudy in Indian Patients [Internet]. Sciencedomain.org. 2018 [cited 15 January 2018]. Available from:

http://www.sciencedomain.org/abstract/1180
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 12 Feb 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.